HFA Premium Access

Safety and proof of biological activity support clinical development of AT-001 for diabetic cardiomyopathy: a phase 1/2 study


About the speaker

Doctor Riccardo Perfetti

Applied Therapeutics Inc., New York (United States of America)
2 presentations
0 follower

14 more presentations in this session

STADE-HF: A Titration based on sST2 is safe but failed to decrease readmissions in patients admitted for acute heart failure.

Speaker: Mr J. Nicoleau (Montpellier, FR)


Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre

Speaker: Miss S. Lyu (Beijing, CN)


Interplay of stress regulatory transcription factors in human cardiac valvular disorders leading to heart failure and cross talk of NFAtc3 nuclear localization invitro.

Speaker: Professor I. Murtaza (Islamabad, PK)


Who is taking care of decompensations of patients after a de novo AHF episode? An outlook on the natural history through the NOVICA cohort

Speaker: Doctor O. Miro (Barcelona, ES)


Analysis on how the emergency physician decision of hospitalization or discharge home patients with acute heart failure matches with the risk categories stratified by the MEESSI scale

Speaker: Doctor O. Miro (Barcelona, ES)


Access the full session

Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Speakers: Doctor R. Perfetti, Mr J. Nicoleau, Miss S. Lyu, Professor I. Murtaza, Doctor O. Miro...

About the event


Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk